|
Kuzmenko A.V., Kuzmenko V.V., Gyaurgiev T.A.
Evaluation of the effect of Alfuprost® MR on detrusor thickness and bladder mass in patients with detrusor hypertrophy caused by benign prostatic hyperplasia
|
№6 / 2023
|
|
A.O. Morozov, E.Yu. Timofeeva, A.Yu. Suvorov, S.N. Allenov, L.G. Spivak
Efficiency and safety of the drug Adenoprosin in patients with prostate diseases. Systematic review and meta-analysis
|
№5 / 2023
|
|
M.I. Katibov, A.B. Bogdanov, Z.M. Magomedov, K.E. Mollaeva
Giant prostate stones: case report
|
№3 / 2023
|
|
M.N. Rustamov, O.F. Galiullin, A.Z. Vinarov
Ejaculatory disorders after surgical treatment of benign prostatic hyperplasia
|
№1 / 2023
|
|
A.V. Kuzmenko, T.A. Gyaurgiev, G.A. Kuzmenko
Our experience of using hexane extract of Serenoa Repens fruit (Permixone) in the treatment of LUTS in clinical practice
|
№2 / 2022
|
|
A.V. Kuzmenko, V.V. Kuzmenko, T.A. Gyaurgiev, Yu.Yu. Vinnik
An observational randomized study of the efficacy and safety of the drug Longidase®, vaginal and rectal suppositories 3000 iu in the treatment of patients with symptoms of the lower urinary tract on the background of benign prostatic hyperplasia
|
№6 / 2021
|
|
D.V. Ergakov, A.G. Martov, D.E. Turin, A.S. Andronov
Lower urinary tract symptoms after transurethral resection of the prostate
|
№1 / 2020
|
|
A.A. Kaputovskij
Tadalafil 5 mg once daily is a rationale option for simultaneous treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction
|
№6 / 2019
|
|
V.Yu. Startsev, V.A. Dudarev, F.A. Sevryukov, N.B. Zabrodina
Economic aspects of treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia
|
№6 / 2019
|
|
A.N. Nizov
Efficacy of 5α-reductase inhibitors in the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia
|
№5 / 2019
|
|
A.A. Kamalov, A.N. Nizov
Efficiency of phosphodiesterase-5 inhibitors for treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia and concomitant erectile dysfunction
|
№4 / 2019
|
|
A.A. Kamalov, R.P. Vasilevskiy, D.A. Okhobotov, E.A. Neplokhov
A comparative characteristics of treatment results of patiens with benign prostatic hyperplasia in combination with hypogonadism
|
№4 / 2019
|
Русский
